Renaud S.
- Country
- France
- Department
- MEDICAL ONCOLOGY
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase 1 Dose Escalation and Cohort Expansion Study of Anti-PD-1 Monoclonal Antibody TSR-042 in Advanced Solid Tumors
- Phase 3 Randomized Open‑Label Study of INCB123667 Versus Investigator’s Choice Chemotherapy Combination in Platinum‑Resistant Ovarian Cancer with Cyclin E1 Overexpression
Data & Insights
Has run more than one trial at 233 of 436 partner sites.
Specializations
Gynecologic Oncology
Specializes in treating various forms of gynecological cancers, with particular emphasis on ovarian cancer and cervical cancer research.
- Advanced ovarian, fallopian tube, and peritoneal cancers
- Locally advanced cervical cancer
- Endometrial cancer therapy
Active in evaluating novel therapeutic combinations including immunotherapy and targeted treatments for gynecologic malignancies.
Breast Cancer Research
Focuses on innovative approaches in treating various subtypes of breast cancer, particularly in advanced disease settings.
- Triple-negative breast cancer
- ER-positive/HER2-negative metastatic disease
- Early detection and molecular monitoring
Investigates circulating tumor DNA-based surveillance strategies and targeted therapeutic approaches.
Therapeutic Innovation
Leads research in precision medicine approaches and novel drug development for solid tumors.
- Antibody-drug conjugates
- Targeted molecular therapies
- Immunotherapy combinations
Explores maintenance treatment strategies and combination approaches for advanced cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.